Axon Enterprise (NASDAQ:AXON) Announces Quarterly Earnings Results

Axon Enterprise (NASDAQ:AXON) issued its quarterly earnings results on Monday. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.20, Briefing.com reports. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The business had revenue of $460.74 million for the quarter, compared to the consensus estimate of $441.57 million. During the same period in the prior year, the firm posted $0.51 earnings per share. The business’s quarterly revenue was up 34.3% on a year-over-year basis. Axon Enterprise updated its FY 2024 guidance to EPS.

Axon Enterprise Stock Down 0.3 %

AXON stock opened at $311.86 on Thursday. Axon Enterprise has a one year low of $175.37 and a one year high of $329.87. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The firm’s fifty day moving average is $310.82 and its 200 day moving average is $267.44. The firm has a market cap of $23.53 billion, a PE ratio of 135.59 and a beta of 0.91.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on AXON. The Goldman Sachs Group upped their target price on Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. JMP Securities restated a “market outperform” rating and set a $375.00 price objective on shares of Axon Enterprise in a report on Tuesday. Barclays lifted their target price on shares of Axon Enterprise from $308.00 to $381.00 and gave the stock an “overweight” rating in a research note on Wednesday. JPMorgan Chase & Co. upped their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. Finally, Robert W. Baird raised their price objective on Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, February 22nd. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $333.08.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.